Prevalence of maternal hepatitis C infection according to HIV serostatus in six Spanish regions (2003-2006)

European Journal of Public Health

Volumn 21, Issue 5, 2011, Pages 643-645

  Seisdedos, Teresa ^a   Díaz, Asunción ^a   Bleda, María José ^a   Ortiz, Marta ^b   García, Alfredo ^b   Díez, Mercedes ^a,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Participant Team in Acknowledgments Section   (Spain)

Author keywords

co infection HIV HCV; hepatitis C; pregnancy; unlinked anonymous studies

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; SPAIN; WESTERN BLOTTING;

BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HIV; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SPAIN;

EID: 80053468952     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckq085     Document Type: Article

References (10)

1. Rantala M, van de Laar M. Surveillance epidemiology of hepatitis B and C in Europe. A review. Eurosurveillance 2008;13:1-8.
2. Wiessing L, Guarita B, Salminen M, et al. European monitoring of notification of hepatitis C virus infection in the general population and among injecting drug users (IDUs)-the need to improve quality and comparability. Eurosurveillance 2008;13:4-6.
3. Echevarria J, Leon P, Pozo F, Avellon A. Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996-2004). Enferm Infecc Microbiol Clin 2006;24:20-5. (Pubitemid 43288605)
4. SPNS, GeSida/SEIMC, SEGO, AEP. Recomendaciones para el seguimiento de la infección por el VIH con relación a la reproducción, el embarazo y la prevención de la transmisión vertical (HIV infection follow-up recommendations, related to reproduction, pregnancy and prevention of perinatal transmission). Available at: http://www.gesida.seimc.org/index.asp. 2007 (22 July 2009, date last accessed).
5. Ades A, Parker S, Walker J, et al. HCV prevalence in pregnant women in the UK. Epidemiol Infect 2000;125:399-405.
6. Conte D, Fraquelli M, Prati D, et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000;31:751-5. (Pubitemid 30118646)
7. Gutiérrez-Zufiaurre N, Sánchez-Hernández J, Munoz S, et al. Seroprevalencia de anticuerpos frente a Treponema pallidum, Toxoplasma gondii, virus de la rubéola, virus de la hepatitis B y C y VIH en mujeres gestantes (Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women). Enferm Infecc Microbiol Clin 2004;22:512-6. (Pubitemid 39582813)
8. Suárez A, Solís G, Otero L, et al. Prevalencia de inmunidad frente a los virus de la hepatitis en gestantes del Area Sanitaria de Gijón (Hepatitis viruses inmunity prevalence in pregnant women in Gijón (Spain)). Gastroenterol Hepatol 2004;27:347-52.
9. Munoz-Almagro C, Juncosa T, Fortuny T, et al. Prevalencia de la infecció n por el virus de la hepatitis C en mujeres embarazadas y transmisión vertical de este virus (Prevalence of hepatitis C virus in pregnant women and vertical transmission). Med Clin 2002;118:452-4.
10. Solís I, Munoz E, Ramos J, et al. Características maternas en una cohorte de gestantes con infección por el VIH-1 (Maternal characteristics of a cohort of pregnant women with HIV-1 infection). Med Clin 2006;127:121-5.